Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of CRL will rise by +2.38% over the next 2 Weeks and hit $273.86 by Friday, August 21, 2026. In that time frame, CRL's share price is expected to range between $264.12 and $283.28.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Aug 21, 2026 | 265.41 | 275.93 | 287.50 |
| Aug 20, 2026 | 268.73 | 280.53 | 291.46 |
| Aug 19, 2026 | 264.61 | 276.78 | 288.24 |
| Aug 18, 2026 | 261.82 | 272.92 | 285.01 |
| Aug 17, 2026 | 258.33 | 269.95 | 281.58 |
| Aug 14, 2026 | 259.92 | 271.69 | 282.94 |
| Aug 13, 2026 | 264.73 | 276.29 | 287.28 |
| Aug 12, 2026 | 260.97 | 272.54 | 284.43 |
| Aug 11, 2026 | 256.98 | 268.68 | 279.65 |
| Aug 10, 2026 | 255.36 | 265.71 | 277.55 |
CRL shares rose +0.75% in Friday, August 7, 2026's trading session, rising from a previous close of $265.51 to move at $267.49. The stock demonstrated notable intraday movement (see CRL's key stats for a full breakdown), fluctuating between $260.86 and $267.59, a +2.58% trading range. While recent weeks have seen some volatility, CRL has managed to secure a +19.26% gain over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 612.48K shares changing hands, 694.36K fewer than the previous session. This amounted to $163.83M in total market activity.
Will CRL Continue Its Upward Trend?
According to analyst ratings and projections for CRL, Charles River Laboratories International, Inc. shares are anticipated to increase by +6.96%, potentially reaching $287.50 per share by August 21, 2026. Short-term technical indicators currently suggest a neutral sentiment for CRL. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 15 positive trading days within the past 30 sessions. Based on the CRL stock forecast, now is a good time to buy CRL stock because its current trading price is -3.06% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on CRL covering social and institutional perspectives.
CRL Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into CRL's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 73.09% to 80.69%) indicate the stock is in a strong bullish momentum phase. The 50-day RSI, at 64.72%, suggests strong medium-term momentum. However, the 100-day RSI, at 59.36%, maintains a neutral outlook for the long term. Insights into CRL's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Charles River Laboratories International Short-Term Forecasts
CRL Forecast For Next 5 Days
Our algorithm anticipates Charles River Laboratories International (CRL) stock could hit $263.89 by Aug 14, 2026. This represents a -1.35% fall from today's price, following a -0.29% change over the past five days.
CRL Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Charles River Laboratories International, Inc. (CRL) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $269.72, which would mean a +0.83% increase from the current price of $267.49. Projections for this period range from a high of $302.26 to a low of $243.54.
CRL Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Charles River Laboratories International's price over the next three months point to a drop. CRL stock is expected to peak at $281.51 on Aug 20, 2026 before potentially dipping to $233.72 on Oct 12, 2026. On average, CRL is likely to trade around $260.85 in the coming 90 days.
Charles River Laboratories International Stock Forecast 2025
Based on our predictive models, Charles River Laboratories International (CRL) is expected to trade between $233.72 and $289.83 throughout 2026. This would result in an average price of $260.61, potentially offering investors a -2.57% return from current levels.
Charles River Laboratories International, Inc. Monthly Forecast 2026–2027
August 2026
According to our latest forecast models, Charles River Laboratories International, Inc. (CRL) is positioned to show a strong performance in August 2026. The price is predicted to move between $248.80 and $281.51, settling at an average of $264.69. This could translate to a -1.05% loss.
September 2026
Based on current market signals, Charles River Laboratories International, Inc. is projected to trend september 2026. We forecast a trading range from $242.52 to $273.07, with a likely average price of $257.17. Investors could expect a potential return of -3.86%.
October 2026
Our predictive algorithms indicate Charles River Laboratories International, Inc. stock may see a shift in October 2026. The expected range spans $233.72–$275.72, with an average target of $259.56. This represents a cautious outlook and a possible loss of -2.96%.
November 2026
Analyzing established trends, Charles River Laboratories International, Inc. looks set to move in November 2026. Projections place the stock between $247.20 and $289.83, averaging around $265.90. This suggests a -0.59% loss from current levels.
December 2026
Market indicators suggest Charles River Laboratories International, Inc. could experience notable changes during December 2026. Prices could fluctuate within $241.62 to $278.62, with a midpoint forecast of $257.26. The stock might deliver a -3.82% loss.
January 2027
Forecasting for January 2027, models estimate that Charles River Laboratories International, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $242.51 and $279.14, averaging $259.17. This signals a cautious trajectory with potential returns around -3.11%.
February 2027
According to our latest forecast models, Charles River Laboratories International, Inc. (CRL) is positioned to show a strong performance in February 2027. The price is predicted to move between $237.81 and $266.27, settling at an average of $251.07. This could translate to a -6.14% loss.
March 2027
Based on current market signals, Charles River Laboratories International, Inc. is projected to trend march 2027. We forecast a trading range from $239.91 to $270.20, with a likely average price of $254.59. Investors could expect a potential return of -4.82%.
April 2027
Our predictive algorithms indicate Charles River Laboratories International, Inc. stock may see a shift in April 2027. The expected range spans $241.58–$274.41, with an average target of $258.94. This represents a cautious outlook and a possible loss of -3.20%.
May 2027
Analyzing established trends, Charles River Laboratories International, Inc. looks set to move in May 2027. Projections place the stock between $234.84 and $272.51, averaging around $251.15. This suggests a -6.11% loss from current levels.
June 2027
Market indicators suggest Charles River Laboratories International, Inc. could experience notable changes during June 2027. Prices could fluctuate within $236.80 to $271.12, with a midpoint forecast of $253.31. The stock might deliver a -5.30% loss.
July 2027
Forecasting for July 2027, models estimate that Charles River Laboratories International, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $232.16 and $259.63, averaging $245.23. This signals a cautious trajectory with potential returns around -8.32%.
August 2027
According to our latest forecast models, Charles River Laboratories International, Inc. (CRL) is positioned to show a strong performance in August 2027. The price is predicted to move between $233.25 and $259.48, settling at an average of $247.26. This could translate to a -7.56% loss.
CRL's history of dividends and stock splits also plays a role in long-term investor confidence.

